Company: VCYT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001384101-25-000051
Chunk: 1

Company: VERACYTE, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 1
---
 meeting. This approach also lowers costs, enables greater participation and is better for the environment.

The matters to be acted upon are described in the accompanying Notice of Annual Meeting and Proxy Statement.

After reading the Proxy Statement, please vote promptly to ensure that your shares will be represented. Whether or not you plan to attend the meeting, please vote by telephone or the internet, or sign and return a proxy card to ensure your representation at the meeting. Your vote is important.

We look forward to seeing you at the Annual Meeting.

Sincerely yours,

/s/ Marc Stapley

Marc Stapley

#### Chief Executive Officer
April 29, 2025

| 6000 Shoreline Court, Suite 300 
 South San Francisco, CA 94080   |

Notice of Annual Meeting of Stockholders

to be held Tuesday, June 17, 2025

To the Stockholders of Veracyte, Inc.: The Annual Meeting of Stockholders (the "Annual Meeting") of Veracyte, Inc., a Delaware corporation (“Veracyte,” the "company," “we,” “us” or “our”), will be held virtually via the internet at www.virtualshareholder meeting.com/VCYT2025 on Tuesday, June 17, 2025, at 10:00 a.m., Pacific Daylight Time, for the following purposes:

| 1 
 2 |     | To elect seven directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified;      
 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025;     |
|:--|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------|
| 3 |     | To approve, on a non-binding advisory basis, the compensation paid by us to our named executive officers as disclosed in this Proxy Statement; |
| 4 |     | To determine, on a non-binding advisory basis, the frequency of advisory votes on the compensation of our named executive officers;            |
| 5 |     | To approve an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan; and                                                                  |
| 6 |     | To transact such other business as may properly come before the Annual Meeting and any postponement or adjournment of the Annual Meeting.      |

Only stockholders of record as of the close of business on April 21, 2025 are entitled to notice of and to vote at